The Role of Endoscopic Ultrasonography in the Diagnosis and Management of Pancreatic Cancer

Gastroenterology Clinics of North America

Volumn 41, Issue 1, 2012, Pages 179-188

  Othman, Mohamed O ^a   Wallace, Michael B ^b  

^a Department of Internal Medicine   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Elastography; Endoscopic ultrasonography; Fine needle aspiration; Pancreatic cancer

Indexed keywords

ALBUNEX; ECHOVIST; GEMCITABINE; LONTUCIREV; PERFLUTREN; SHU 508; SONOVUE; TUMOR NECROSIS FACTOR ALPHA;

ASPIRATION BIOPSY; CANCER STAGING; CANCER SURVIVAL; CELL THERAPY; CELLULAR IMMUNITY; CHROMOSOME ABERRATION; CHRONIC PANCREATITIS; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED DRUG THERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOENDOSCOPE; ELASTOGRAPHY; ENDOSCOPE; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CANCER; FIDUCIAL MARKER; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; HUMAN; INTERMETHOD COMPARISON; MIXED LYMPHOCYTE CULTURE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PANCREAS CANCER; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); REVIEW; SENSITIVITY AND SPECIFICITY; SOFT TISSUE SARCOMA; SOLID TUMOR; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL TIME;

ENDOSONOGRAPHY; HUMANS; PANCREATIC NEOPLASMS;

EID: 84857094272     PISSN: 08898553     EISSN: 15581942     Source Type: Journal    
DOI: 10.1016/j.gtc.2011.12.014     Document Type: Review

References (61)

1. American Cancer Society, 2010 Cancer Facts and Figures 2010, Accessed December 8, 2011. http://www.cancer.org/acs/groups/content/epidemiologysurveilance/documents/document/acspc-026238.pdf.
2. Zhou J., Enewold L., Stojadinovic A., et al. Incidence rates of exocrine and endocrine pancreatic cancers in the United States. Cancer Causes Control 2010, 21:853-861.
3. Saif M.W. Pancreatic neoplasm in 2011: an update. JOP 2011, 12:316-321.
4. Ngamruengphong S., Li F., Zhou Y., et al. EUS and survival in patients with pancreatic cancer: a population-based study. Gastrointest Endosc 2010, 72:78-83.
5. Chang K.J., Nguyen P., Erickson R.A., et al. The clinical utility of endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of pancreatic carcinoma. Gastrointest Endosc 1997, 45:387-393.
6. Eloubeidi M.A., Jhala D., Chhieng D.C., et al. Yield of endoscopic ultrasound-guided fine-needle aspiration biopsy in patients with suspected pancreatic carcinoma. Cancer 2003, 99:285-292.
7. Siddiqui A.A., Brown L.J., Hong S.K., et al. Relationship of pancreatic mass size and diagnostic yield of endoscopic ultrasound-guided fine needle aspiration. Dig Dis Sci 2011, 56:3370-3375.
8. Agarwal B., Abu-Hamda E., Molke K.L., et al. Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer. Am J Gastroenterol 2004, 99:844-850.
9. Legmann P., Vignaux O., Dousset B., et al. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol 1998, 170:1315-1322.
10. Bronstein Y.L., Loyer E.M., Kaur H., et al. Detection of small pancreatic tumors with multiphasic helical CT. AJR Am J Roentgenol 2004, 182:619-623.
11. Koelblinger C., Ba-Ssalamah A., Goetzinger P., et al. Gadobenate dimeglumine-enhanced 3.0-T MR imaging versus multiphasic 64-detector row CT: prospective evaluation in patients suspected of having pancreatic cancer. Radiology 2011, 259:757-766.
12. Arslan A., Buanes T., Geitung J.T. Pancreatic carcinoma: MR, MR angiography and dynamic helical CT in the evaluation of vascular invasion. Eur J Radiol 2001, 38:151-159.
13. van Hemel B.M., Lamprou A.A., Weersma R., et al. Procedure-related, false-positive cytology results during EUS-guided FNA in patients with esophageal cancer. Gastrointest Endosc 2010, 71:1130-1133.
14. Soriano A., Castells A., Ayuso C., et al. Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am J Gastroenterol 2004, 99:492-501.
15. Tian Y.T., Wang C.F., Wang G.Q., et al. [Prospective evaluation of the clinical significance of ultrasonography, helical computed tomography, magnetic resonance imaging and endoscopic ultrasonography in the assessment of vascular invasion and lymph node metastasis of pancreatic carcinoma]. Zhonghua zhong liu za zhi [Chinese Journal of Oncology] 2008, 30:682-685.
16. Othman M.O., Raimondo M. Endoscopic ultrasound fine needle aspiration of pancreatic lesions: Is a smaller needle safer and better?. Dig Liver Dis 2011, 43:587-588.
17. Erickson R.A., Sayage-Rabie L., Beissner R.S. Factors predicting the number of EUS-guided fine-needle passes for diagnosis of pancreatic malignancies. Gastrointest Endosc 2000, 51:184-190.
18. LeBlanc J.K., Ciaccia D., Al-Assi M.T., et al. Optimal number of EUS-guided fine needle passes needed to obtain a correct diagnosis. Gastrointest Endosc 2004, 59:475-481.
19. Moller K., Papanikolaou I.S., Toermer T., et al. EUS-guided FNA of solid pancreatic masses: high yield of 2 passes with combined histologic-cytologic analysis. Gastrointest Endosc 2009, 70:60-69.
20. Fabbri C., Polifemo A.M., Luigiano C., et al. Endoscopic ultrasound-guided fine needle aspiration with 22- and 25-gauge needles in solid pancreatic masses: a prospective comparative study with randomisation of needle sequence. Dig Liver Dis 2011, 43:647-652.
21. Sakamoto H., Kitano M., Komaki T., et al. Prospective comparative study of the EUS guided 25-gauge FNA needle with the 19-gauge Trucut needle and 22-gauge FNA needle in patients with solid pancreatic masses. J Gastroenterol Hepatol 2009, 24:384-390.
22. Hikichi T., Irisawa A., Bhutani M.S., et al. Endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses with rapid on-site cytological evaluation by endosonographers without attendance of cytopathologists. J Gastroenterol 2009, 44:322-328.
23. Savoy A.D., Raimondo M., Woodward T.A., et al. Can endosonographers evaluate on-site cytologic adequacy?. A comparison with cytotechnologists. Gastrointest Endosc 2007, 65:953-957.
24. Jhala N.C., Eltoum I.A., Eloubeidi M.A., et al. Providing on-site diagnosis of malignancy on endoscopic-ultrasound-guided fine-needle aspirates: should it be done?. Ann Diagn Pathol 2007, 11:176-181.
25. Klapman J.B., Logrono R., Dye C.E., et al. Clinical impact of on-site cytopathology interpretation on endoscopic ultrasound-guided fine needle aspiration. Am J Gastroenterol 2003, 98:1289-1294.
26. Varadarajulu S., Tamhane A., Eloubeidi M.A. Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis. Gastrointest Endosc 2005, 62:728-736.
27. Fritscher-Ravens A., Brand L., Knofel W.T., et al. Comparison of endoscopic ultrasound-guided fine needle aspiration for focal pancreatic lesions in patients with normal parenchyma and chronic pancreatitis. J Gastroenterol 2002, 97:2768-2775.
28. Bhutani M.S., Gress F.G., Giovannini M., et al. The No Endosonographic Detection of Tumor (NEST) study: a case series of pancreatic cancers missed on endoscopic ultrasonography. Endoscopy 2004, 36:385-389.
29. Siddiqui A.A., Kowalski T.E., Shahid H., et al. False-positive EUS-guided FNA cytology for solid pancreatic lesions. Gastrointest Endosc 2011, 74:535-540.
30. Ophir J., Cespedes I., Ponnekanti H., et al. Elastography: a quantitative method for imaging the elasticity of biological tissues. Ultrasonic Imaging 1991, 13:111-134.
31. Saftoiu A. State-of-the-art imaging techniques in endoscopic ultrasound. World J Gastroenterol 2011, 17:691-696.
32. Saftoiu A., Vilmann P., Gorunescu F., et al. Neural network analysis of dynamic sequences of EUS elastography used for the differential diagnosis of chronic pancreatitis and pancreatic cancer. Gastrointest Endosc 2008, 68:1086-1094.
33. Iglesias-Garcia J., Larino-Noia J., Abdulkader I., et al. EUS elastography for the characterization of solid pancreatic masses. Gastrointest Endosc 2009, 70:1101-1108.
34. Giovannini M., Hookey L.C., Bories E., et al. Endoscopic ultrasound elastography: the first step towards virtual biopsy?. Preliminary results in 49 patients. Endoscopy 2006, 38:344-348.
35. Janssen J., Schlorer E., Greiner L. EUS elastography of the pancreas: feasibility and pattern description of the normal pancreas, chronic pancreatitis, and focal pancreatic lesions. Gastrointest Endosc 2007, 65:971-978.
36. Hirche T.O., Ignee A., Barreiros A.P., et al. Indications and limitations of endoscopic ultrasound elastography for evaluation of focal pancreatic lesions. Endoscopy 2008, 40:910-917.
37. Iglesias-Garcia J., Larino-Noia J., Abdulkader I., et al. Quantitative endoscopic ultrasound elastography: an accurate method for the differentiation of solid pancreatic masses. Gastroenterology 2010, 139:1172-1180.
38. Schrader H., Wiese M., Ellrichmann M., et al. Diagnostic value of quantitative EUS elastography for malignant pancreatic tumors: relationship with pancreatic fibrosis. Ultraschall Med 2011 May 31, [Epub ahead of print].
39. Saftoiu A., Vilman P. Endoscopic ultrasound elastography: a new imaging technique for the visualization of tissue elasticity distribution. J Gastrointestin Liver Dis 2006, 15:161-165.
40. Giovannini M. Contrast-enhanced and 3-dimensional endoscopic ultrasonography. Gastroenterol Clin North Am 2010, 39:845-858.
41. Claudon M., Cosgrove D., Albrecht T., et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS): update 2008. Ultraschall Med 2008, 29:28-44.
42. Romagnuolo J., Hoffman B., Vela S., et al. Accuracy of contrast-enhanced harmonic EUS with a second-generation perflutren lipid microsphere contrast agent (with video). Gastrointest Endosc Jan 2011, 73:52-63.
43. Napoleon B., Alvarez-Sanchez M.V., Gincoul R., et al. Contrast-enhanced harmonic endoscopic ultrasound in solid lesions of the pancreas: results of a pilot study. Endoscopy 2010, 42:564-570.
44. Sakamoto H., Kitano M., Suetomi Y., et al. Utility of contrast-enhanced endoscopic ultrasonography for diagnosis of small pancreatic carcinomas. Ultrasound Med Biol 2008, 34:525-532.
45. Imazu H., Uchiyama Y., Matsunaga K., et al. Contrast-enhanced harmonic EUS with novel ultrasonographic contrast (Sonazoid) in the preoperative T-staging for pancreaticobiliary malignancies. Scand J Gastroenterol 2010, 45:732-738.
46. Kubiliun N., Ribeiro A., Fan Y.S., et al. EUS-FNA with rescue fluorescence in situ hybridization for the diagnosis of pancreatic carcinoma in patients with inconclusive on-site cytopathology results. Gastrointest Endosc 2011, 74:541-547.
47. Mishra G., Zhao Y., Sweeney J., et al. Determination of qualitative telomerase activity as an adjunct to the diagnosis of pancreatic adenocarcinoma by EUS-guided fine-needle aspiration. Gastrointest Endosc 2006, 63:648-654.
48. Takahashi K., Yamao K., Okubo K., et al. Differential diagnosis of pancreatic cancer and focal pancreatitis by using EUS-guided FNA. Gastrointest Endosc Jan 2005, 61:76-79.
49. Salek C., Benesova L., Zavoral M., et al. Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer. World J Gastroenterol 2007, 13:3714-3720.
50. Timmerman R.D., Kavanagh B.D., Cho L.C., et al. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 2007, 25:947-952.
51. Koong A.C., Christofferson E., Le Q.T., et al. Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Physics 2005, 63:320-323.
52. Park W.G., Yan B.M., Schellenberg D., et al. EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy. Gastrointest Endosc 2010, 71:513-518.
53. Sanders M.K., Moser A.J., Khalid A., et al. EUS-guided fiducial placement for stereotactic body radiotherapy in locally advanced and recurrent pancreatic cancer. Gastrointest Endosc 2010, 71:1178-1184.
54. DiMaio C.J., Nagula S., Goodman K.A., et al. EUS-guided fiducial placement for image-guided radiation therapy in GI malignancies by using a 22-gauge needle (with videos). Gastrointest Endosc 2010, 71:1204-1210.
55. Chang K.J., Nguyen P.T., Thompson J.A., et al. Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound-guided fine-needle injection in patients with advanced pancreatic carcinoma. Cancer 2000, 88:1325-1335.
56. Hecht J.R., Bedford R., Abbruzzese J.L., et al. A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma. Clin Cancer Res 2003, 9:555-561.
57. Irisawa A., Takagi T., Kanazawa M., et al. Endoscopic ultrasound-guided fine-needle injection of immature dendritic cells into advanced pancreatic cancer refractory to gemcitabine: a pilot study. Pancreas 2007, 35:189-190.
58. Wallach D., Varfolomeev E.E., Malinin N.L., et al. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 1999, 17:331-367.
59. McLoughlin J.M., McCarty T.M., Cunningham C., et al. TNFerade, an adenovector carrying the transgene for human tumor necrosis factor alpha, for patients with advanced solid tumors: surgical experience and long-term follow-up. Ann Surg Oncol 2005, 128:25-30.
60. Senzer N., Mani S., Rosemurgy A., et al. TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors. J Clin Oncol 2004, 22:592-601.
61. Chang K.J., Lee J.G., Holcombe R.F., et al. Endoscopic ultrasound delivery of an antitumor agent to treat a case of pancreatic cancer. Nat Clin Pract Gastroenterol Hepatol 2008, 5:107-111.